ABL

Abbott Laboratories · BX:ABL

89.02 CHF2.18 +2.51%

Abbott Laboratories (BX:ABL) last traded at 89.02 CHF, up 2.51% on the day. Over the past year the stock is down 10.62%. Its 52-week range is 64.73 to 104.38. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open87.50

Day range87.50 – 89.02

52-week range64.73 – 104.38

Volume123

Average volume (10 days)19

Market cap (USD)183.77 B

P/E39.32

EPS (TTM) (USD)2.71

Dividend yield2.37%

Beta (1 year)0.4244

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+3.98%1 week

+10.17%1 month

+2.16%3 months

+29.77%6 months

−9.44%Year to date

−10.62%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.